111,95 €
111,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
56 °P sammeln
111,95 €
111,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
56 °P sammeln
Als Download kaufen
111,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
56 °P sammeln
Jetzt verschenken
111,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
56 °P sammeln
  • Format: ePub

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics. This volume covers AEG-1/MTDH/Lyric implicated in multiple human cancers.
Provides information on cancer research | Outstanding and original reviews | Suitable for researchers and students

  • Geräte: eReader
  • mit Kopierschutz
  • eBook Hilfe
  • Größe: 2.37MB
Produktbeschreibung
Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics. This volume covers AEG-1/MTDH/Lyric implicated in multiple human cancers.

  • Provides information on cancer research
  • Outstanding and original reviews
  • Suitable for researchers and students

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Dr. Sarkar received his MBBS from Dhaka Medical College, Bangladesh and PhD from Nagoya University, Japan. After postdoctoral training in Columbia University, NY he joined Virginia Commonwealth University (VCU) as a faculty where he is now a Professor in the Department of Human and Molecular Genetics, and Associate Director of Education and Training at Massey Cancer Center. Dr. Sarkar's research focuses on identifying novel regulators of hepatocellular carcinoma (HCC), especially obesity-induced HCC, and developing targeted gene- and immunotherapy based on the accrued knowledge. Dr. Sarkar has published more than 280 papers and his research is funded by NCI, NIDDK and DOD.
Rezensionen
Praise for the Serial"This classic and essential series presents critical overviews on select aspects of both cancer research and the basic underlying sciences." --American Scientist"Excellent, highly informative, in-depth reviews.expertly written, up-to-date, and well-referenced." --Journal of Medicinal Chemistry"This is a series that has a long tradition of excellence in the field of cancer biology." --Doody's Publishing Reviews